2024
|
P/S
|
Downloadable and recorded software to assist health care practitioners in assessment of patients ... |
|
P/S
|
Educational services, namely, providing online training, educational information, awareness, tool... |
|
P/S
|
Research and development of pharmaceutical preparations; research and development of pharmaceutic... |
2023
|
Invention
|
3d particle imaging in pharmaceutical containers.
A method of aligning images for 3D imaging of ... |
|
Invention
|
Drug delivery device.
A drug delivery device may include a housing defining a longitudinal axis ... |
|
Invention
|
Electrophoretic mass spectrometry probes and systems and uses thereof.
The invention generally r... |
|
Invention
|
Protein biomarker and uses thereof.
The present invention is directed to methods of identifying ... |
|
Invention
|
Novel prmt5 inhibitors.
Described herein are novel PRMT5 inhibitors of Formula I and pharmaceuti... |
|
Invention
|
Dosing regimen of kras g12c inhibitor.
Provided herein are methods of administering a KRAS G12C ... |
|
P/S
|
Pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used fo... |
|
Invention
|
Fgf21 mutants and uses thereof.
The invention provides nucleic acid molecules encoding FGF21 mut... |
|
P/S
|
Pharmaceutical preparations and substances for the treatment of cancer and cardiovascular disease... |
|
P/S
|
Pharmaceutical preparations and substances for the treatment
of cancer and cardiovascular diseas... |
|
Invention
|
Tethered heterocyclic inhibitors of kras g12c mutant proteins and uses thereof. KRASKRAS protein,... |
|
Invention
|
Heterocyclic inhibitors of kras g12c mutant proteins and uses thereof. The present disclosure pro... |
|
Invention
|
Heterocyclic inhibitors of kras g12c mutant proteins and uses thereof. KRAS KRAS protein, pharmac... |
|
Invention
|
Combination therapies comprising t-cell redirecting therapies and agonistic anti-il-2r antibodies... |
|
P/S
|
Printed educational materials in the cardiovascular field Online non-downloadable educational mat... |
|
Invention
|
Combinations of a b-raf inhibitor, and an anti-egfr antibody for the treatment of cancer. Provide... |
|
P/S
|
pharmaceutical preparations and substances for use in the treatment of hematological, immune, aut... |
|
Invention
|
Systems and methods for estimating tumor growth. A method for estimating tumor growth dynamics in... |
|
Invention
|
Systems and methods for estimating tumor growth.
A method for estimating tumor growth dynamics i... |
|
Invention
|
A method for harvesting products from perfusion cultures. The disclosure provides methods of puri... |
|
Invention
|
Bispecific molecule stabilizing composition. The present invention provides provide a pharmaceuti... |
|
Invention
|
Just-in-time learning with variational autoencoder for cell culture process monitoring and/or con... |
|
Invention
|
Large scale bioreactor system and method. A large scale bioreactor system includes a stainless st... |
|
Invention
|
Large scale bioreactor system and method.
A large scale bioreactor system includes a stainless s... |
|
P/S
|
Pharmaceutical preparations and substances for use in the
treatment of hematological, immune, au... |
|
P/S
|
Pharmaceutical preparations and substances for use in the treatment of hematological, immune, aut... |
|
Invention
|
Lean perfusion cell culture methods. Described herein is a low perfusion rate cell culture method... |
|
Invention
|
Lean perfusion cell culture methods.
Described herein is a low perfusion rate cell culture metho... |
|
Invention
|
Optical systems and platforms for simultaneously analyzing multiple solution properties. Disclose... |
|
Invention
|
System and method of limiting subvisible particles in a syringe. A method of limiting subvisible ... |
|
Invention
|
Autoinjector with removable cap |
|
Invention
|
Predictive model to evaluate processing time impacts. Systems and methods for evaluating impacts ... |
|
P/S
|
Pharmaceutical preparations and substances for use in the treatment of hematological, autoimmune,... |
|
Invention
|
Live cell profiling assay. A method is provided, comprising: analyzing a first image, captured by... |
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment ... |
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations and
substances for use in the treatment... |
|
Invention
|
Rnai constructs and methods for inhibiting fam13a expression.
The present application relates to... |
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations used for the treatment of cancer; pharma... |
|
P/S
|
Pharmaceutical preparations; pharmaceutical preparations
used for the treatment of cancer; pharm... |
|
P/S
|
pharmaceutical preparations; pharmaceutical preparations and substances for use in the treatment ... |
|
Invention
|
Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods o... |
|
P/S
|
Injectors pre-filled with pharmaceutical preparations for treating cancer and immune diseases and... |
|
P/S
|
Injectors pre-filled with pharmaceutical preparations for
treating cancer and immune diseases an... |
|
P/S
|
Medical information relating to oncology |
|
Invention
|
Systems and methods for delayed drug delivery.
Systems and methods for delayed delivery of a dru... |
2022
|
Invention
|
Sotorasib dosing regimen. The present disclosure provides method of administering sotorasib to a ... |
|
Invention
|
Parallel chromatography systems and methods.
Parallel chromatography systems and continuous manu... |
|
Invention
|
Non-terminal antibody discovery methods and single cell assays.
Provided herein are methods of m... |
|
Invention
|
Enhanced hybridoma generation.
Provided herein are methods of generating hybridomas and related ... |
|
Invention
|
Tricyclic-amido-bicyclic prmt5 inhibitors.
Described herein are novel PRMT5 inhibitors of Formul... |
|
Invention
|
High-throughput automated reconstitution of lyophilized drug product.
A drug product reconstitut... |
|
Invention
|
Systems and approaches for drug processing.
A drug processing system includes a workstation, at ... |
|
Invention
|
Coaxial needle adapter and guide bracket for robotic liquid handling platform.
A drug reconstitu... |
|
Invention
|
Materials and methods for monitoring cancer by administering an anti-mcl1 antibody.
The disclosu... |
|
Invention
|
Use of kras g12c inhibitor in treating cancers.
The present disclosure provides uses for a KRASG... |
2021
|
Invention
|
Mage-b2-specific t-cell receptors.
Provided herein are T-cell receptors (TCRs) that when express... |
|
Invention
|
Cell culture method.
The disclosure provides a method of producing etanercept from Chinese hamst... |
|
Invention
|
Trem2 agonist biomarkers and methods of use thereof.
The present invention provides a method of ... |
|
Invention
|
Image augmentation techniques for automated visual inspection.
Various techniques facilitate the... |
|
Invention
|
Tricyclic carboxamide derivatives as prmt5 inhibitors.
Described herein are compounds of Formula... |
2020
|
Invention
|
Drug delivery device and system.
A drug delivery device for delivering a medicament includes a h... |
|
Invention
|
Drug delivery device and system.
A drug delivery device for delivering a medicament includes a p... |
|
Invention
|
Cassette for an autoinjector and related methods.
A cassette for a drug delivery device is descr... |
|
Invention
|
Drug delivery device.
A drug delivery device may include a housing having an opening, a drug sto... |
|
Invention
|
Needle insertion mechanism for drug delivery device.
A drug delivery device includes a housing, ... |